AMAG PHARMACEUTICALS, INC. Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AMAG PHARMACEUTICALS, INC. for November 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Sell | D | 0.00 | 43,898 | 0 | 0 | 43.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 1,200 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Sell | D | 0.00 | 18,949 | 0 | 0 | 18.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 9,452 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Sell | D | 0.00 | 3,499,428 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Sell | D | 0.00 | 14,676 | 0 | 0 | 14.7 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Caligan Partners LP | 10% Owner | Sell | D | 0.00 | 3,499,428 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 17,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 6,900 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 7,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Sell | D | 0.00 | 43,898 | 0 | 0 | 43.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Sell | D | 0.00 | 28,155 | 0 | 0 | 28.2 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 1,200 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Phillips Anne M. | Director | Sell | D | 0.00 | 18,949 | 0 | 0 | 18.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 9,452 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 317 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Sell | D | 0.00 | 3,499,428 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | JOHNSON DAVID EDWARD | Director | Sell | D | 0.00 | 14,676 | 0 | 0 | 14.7 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Sell | D | 0.00 | 35,090 | 0 | 0 | 35.1 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Caligan Partners LP | 10% Owner | Sell | D | 0.00 | 3,499,428 | 0 | 0 | 3.5 M to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 17,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 6,900 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Option Exercise | D | 0.00 | 7,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Schick Kelly | Chief Human Resourc ... | Sell | D | 0.00 | 28,155 | 0 | 0 | 28.2 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Sell | D | 0.00 | 92,244 | 0 | 0 | 92.2 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 317 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 7,600 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SULAT JAMES R | Director | Sell | D | 0.00 | 35,090 | 0 | 0 | 35.1 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 950 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Sell | D | 0.00 | 41,473 | 0 | 0 | 41.5 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 1,200 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Option Exercise | D | 0.00 | 30,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Vittiglio Joseph | Chief Business Offi ... | Sell | D | 0.00 | 92,244 | 0 | 0 | 92.2 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Sell | D | 0.00 | 18,949 | 0 | 0 | 18.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Myers Scott Dunseth | President & CEO | Option Exercise | D | 0.00 | 1,000,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Piekos Brian | Chief Financial Off ... | Option Exercise | D | 0.00 | 9,500 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Piekos Brian | Chief Financial Off ... | Sell | D | 0.00 | 31,538 | 0 | 0 | 31.5 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 7,600 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 3,800 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 950 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | SANTINI GINO | Director | Sell | D | 0.00 | 41,473 | 0 | 0 | 41.5 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 1,200 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | O'Brien Kathrine | Director | Sell | D | 0.00 | 18,949 | 0 | 0 | 18.9 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Myers Scott Dunseth | President & CEO | Option Exercise | D | 0.00 | 1,000,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Piekos Brian | Chief Financial Off ... | Option Exercise | D | 0.00 | 9,500 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Piekos Brian | Chief Financial Off ... | Sell | D | 0.00 | 31,538 | 0 | 0 | 31.5 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 17,326 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 7,543 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 10,110 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 12,787 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 3,575 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 2,534 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Fallon John A. | Director | Sell | D | 0.00 | 37,362 | 0 | 0 | 37.4 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 40,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 16,156 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 8,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 18,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 8,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Option Exercise | D | 0.00 | 20,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | Casciano Anthony | Chief Operating Off ... | Sell | D | 0.00 | 76,349 | 0 | 0 | 76.3 K to 0 (-100.00 %) |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | FONTEYNE PAUL R. | Director | Option Exercise | D | 0.00 | 21,289 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | FONTEYNE PAUL R. | Director | Option Exercise | D | 0.00 | 9,452 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | FONTEYNE PAUL R. | Director | Option Exercise | D | 0.00 | 6,000 | 0 | 0 | |
| Nov 17 2020 | AVM | AMAG PHARMACEUTICA ... | FONTEYNE PAUL R. | Director | Sell | D | 0.00 | 14,676 | 0 | 0 | 14.7 K to 0 (-100.00 %) |